Exhibit 99.1 Pursuant to General Instruction number 4(b)(v) to Form 4, the following additional reporting persons are covered by this joint filing: Name: Foresite Capital Fund II, L.P. Foresite Capital Management III, LLC Foresite Capital Fund III, L.P. Address: Foresite Capital 600 Montgomery Street Street Suite 4500 San Francisco, CA 94111 Name: James B. Tananbaum Address: 3052 Pacific Avenue San Francisco, CA 94115 Designated Filer: Foresite Capital Management II, LLC Issuer and Ticker Symbol: Aerie Pharmaceuticals, Inc. (AERI) Date of Event Requiring Statement:July 22, 2016 FORESITE CAPITAL MANAGEMENT II, LLC By: /s/ Dennis D. Ryan -------------------------------- Dennis D. Ryan Chief Financial Officer FORESITE CAPITAL FUND II, L.P By: Foresite Capital Management II, LLC Its General Partner By: /s/ Dennis D. Ryan -------------------------------- Dennis D. Ryan Chief Financial Officer FORESITE CAPITAL MANAGEMENT III, LLC By: /s/ Dennis D. Ryan -------------------------------- Dennis D. Ryan Chief Financial Officer FORESITE CAPITAL FUND III, L.P By: Foresite Capital Management III, LLC Its General Partner By: /s/ Dennis D. Ryan -------------------------------- Dennis D. Ryan Chief Financial Officer /s/ James B. Tananbaum ---------------------------------------- James B. Tananbaum
- Company Dashboard
- Filings
- Holdings
-
4 Filing
Foresite Capital Management III Form 4AERIE PHARMACEUTICALS / James B. Tananbaum ownership change
Filed: 26 Jul 16, 12:00am